Ignite Creation Date:
2024-05-05 @ 4:53 PM
Last Modification Date:
2024-10-26 @ 9:25 AM
Study NCT ID:
NCT00334295
Status:
COMPLETED
Last Update Posted:
2012-07-31
First Post:
2006-06-05
Brief Title:
Fulvestrant for the Treatment of Recurrent or Metastatic Endometrial Carcinoma
Sponsor:
AstraZeneca
Organization:
AstraZeneca
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Endometrial Carcinoma |
Keywords:
| Name | View |
|---|---|
| Recurrent or metastatic endometrial carcinoma | View |